MacroGenics
MGNX
#8677
Rank
NZ$0.29 B
Marketcap
NZ$4.69
Share price
-6.51%
Change (1 day)
37.47%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.29 Billion

As of March 2026 MacroGenics has a market cap of NZ$0.29 Billion. This makes MacroGenics the world's 8677th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.29 B69.49%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Mar 23rd, 2026 the market cap of MacroGenics was reported to be:

NZ$0.31 Billion
by Nasdaq info icon info icon
NZ$0.31 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$263.43 B 88,287.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.388 T 465,712.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$322.64 B 108,153.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$294.52 B 98,715.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$494.23 B 165,721.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$200.76 B 67,259.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.49 B 402.57%๐Ÿ‡บ๐Ÿ‡ธ USA